Search Result
Results for "
(S)-enantiomer
" in MedChemExpress (MCE) Product Catalog:
3
Biochemical Assay Reagents
12
Isotope-Labeled Compounds
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-121203
-
|
|
Serotonin Transporter
|
Neurological Disease
Cancer
|
|
Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
|
-
-
- HY-100815A
-
|
L-AMPA
|
iGluR
|
Neurological Disease
|
|
(S)-AMPA (L-AMPA), an active S-enantiomer of AMPA, is a potent and selective AMPA receptor agonist .
|
-
-
- HY-78131A
-
|
Dexibuprofen
|
COX
|
Inflammation/Immunology
Cancer
|
|
(S)-(+)-Ibuprofen ((S)-Ibuprofen), a S(+)-enantiomer of Ibuprofen, is a potent COX-1 and COX-2 inhibitor with IC50s of 2.1 μM and 1.6 μM, respectively. (S)-(+)-Ibuprofen has analgesic, anti-inflammatory, anticancer and antipyretic effects .
|
-
-
- HY-50856A
-
|
S-Ruxolitinib; S-INCB18424
|
JAK
|
Cancer
|
|
Ruxolitinib (S enantiomer) (S-Ruxolitinib) is the S-enantiomer of Ruxolitinib (HY-50856). Ruxolitinib (S enantiomer) is an orally active, potent JAK inhibitor .
|
-
-
- HY-B0006B
-
|
(S)-BM 14190
|
Adrenergic Receptor
|
Cardiovascular Disease
|
|
(S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX) .
|
-
-
- HY-B1059
-
-
-
- HY-W018499
-
|
|
Endogenous Metabolite
|
Others
|
|
(S)-2-Hydroxybutanoic acid is the S-enantiomer of 2-Hydroxybutanoic acid. 2-Hydroxybutanoic acid, a coproduct of protein metabolism, is an insulin resistance (IR) biomarker .
|
-
-
- HY-14658A
-
-
-
- HY-Y0816
-
|
|
Biochemical Assay Reagents
|
Others
|
|
(S)-Mandelic Acid is a (S)-enantiomer of Mandelic Acid (HY-W015591). (S)-Mandelic Acid undergoes one-directional chiral inversion to (R)-Mandelic Acid in rat models. (S)-Mandelic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
|
-
-
- HY-W074930
-
|
(S)-GS 1278; (S)-PMPA; (S)-TDF
|
HIV
HBV
|
Infection
|
|
(S)-Tenofovir is the less active S-enantiomer of Tenofovir (HY-13910). Tenofovir is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV). (S)-Tenofovir has low activity to Orf virus. (S)-Tenofovir can be used for research on contagious pustular dermatitis .
|
-
-
- HY-19323A
-
|
(S)-AZD6738
|
ATM/ATR
|
Cancer
|
|
(S)-Ceralasertib ((S)-AZD6738) is the S-enantiomer of Ceralasertib (HY-19323). (S)-Ceralasertib is the inhibitor for ataxia telangiectasia mutated and rad3 related (ATR) .
|
-
-
- HY-15319B
-
|
|
CXCR
|
Others
|
|
AMG 487 S-enantiomer is the S enantiomer of AMG 487. AMG 487 is an antagonist of the chemokine receptor CXCR3.
|
-
-
- HY-132809A
-
-
-
- HY-14855A
-
|
(S)-TR 700; (S)-DA 7157
|
Bacterial
Antibiotic
|
Infection
|
|
(S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. (S)-Tedizolid is the less active isomer.
|
-
-
- HY-10502A
-
|
IND-58359 S enantiomer; (S)-(-)-R-115777
|
Farnesyl Transferase
|
Cancer
|
|
Tipifarnib S enantiomer is the S-enantiomer of Tipifarnib. Tipifarnib is a potent and specific farnesyltransferase (FTase) inhibitor with IC50 of 0.6 nM. Tipifarnib S enantiomer is the less active isomer.
|
-
-
- HY-40354C
-
|
|
JAK
|
Inflammation/Immunology
|
|
(3S,4S)-Tofacitinib is the less active S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.
|
-
-
- HY-100742B
-
|
|
Lactate Dehydrogenase
|
Cancer
|
|
(S)-GNE-140 (Compound 30-S) is the S-enantiomer of GNE-140 (HY-118241). (S)-GNE-140 is an effective lactate dehydrogenase (LDH) inhibitor, with IC50 values of 55 nM for LDHA and 140 nM for LDHB. (S)-GNE-140 can be used in cancer research .
|
-
-
- HY-N2037C
-
|
(S)-Norcoclaurine hydrobromide
|
Endogenous Metabolite
|
Others
|
|
(S)-Higenamine ((S)-Norcoclaurine) hydrobromide, a S-enantiomer of Higenamine, is the entry compound in benzylisoquinoline alkaloid biosynthesis. (S)-Higenamine hydrobromide is produced by the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) by norcoclaurine synthase (NCS) .
|
-
-
- HY-156681A
-
|
(S)-STX-478; (S)-STX-478-101; (S)-LY4064809
|
PI3K
|
Cancer
|
|
(S)-STX-478 is the S-enantiomer of STX-478. STX-478 is a selective inhibitor of PI3Kα mutants, preventing metabolic dysfunction and demonstrating antitumor activity in xenograft mouse models with PI3Kα mutant tumors .
|
-
-
- HY-12871C
-
|
BAY-1143572 S-enantiomer; (+)-Atuveciclib; (+)-BAY-1143572
|
CDK
|
Cancer
|
|
Atuveciclib S-Enantiomer (BAY-1143572 S-Enantiomer) is a potent and selective CDK9 inhibitor, which inhibits CDK9/CycT1 with an IC50 of 16 nM.
|
-
-
- HY-101533B
-
|
|
Bcl-2 Family
|
Cancer
|
|
AZD-5991 S-enantiomer is the less active enantiomer of AZD-5991. AZD-5991 S-enantiomer is a Mcl-1 inhibitor with an IC50 of 6.3 μM in FRET assay and a Kd of 0.98 μM in surface plasmon resonance (SPR) assay.
|
-
-
- HY-15458A
-
|
|
VEGFR
|
Cancer
|
|
(S)-SAR131675 is the S-enantiomer of SAR131675 (HY-15458), a potent and selective VEGFR3 inhibitor and a click chemistry reagent .
|
-
-
- HY-139611B
-
|
(S)-MRTX-1719; (S)-BMS-986504
|
Histone Methyltransferase
|
Cancer
|
|
(S)-Navlimetostat (example 16-7) is the S-enantiomer of Navlimetostat. (S)-Navlimetostat is a PRMT5/MTA complex inhibitor, with an IC50 of 7070 nM .
|
-
-
- HY-129356A
-
|
|
Drug Isomer
|
Cancer
|
|
(S)-Seco-Duocarmycin SA is the S-enantiomer of Seco-Duocarmycin SA (HY-129356). Seco-Duocarmycin SA can be used for cancer research .
|
-
-
- HY-122751
-
|
|
Phosphodiesterase (PDE)
|
Cancer
|
|
(R)-DNMDP is a potent and selective cancer cell cytotoxic agent. (R)-DNMDP, the R-form of DNMDP, binds PDE3A directly. (R)-DNMDP has a 500-fold lower EC50 compared to the (S)-enantiomer in HeLa cell line .
|
-
-
- HY-161573A
-
|
|
YAP
GGTase
|
Cancer
|
|
(7S)-BAY-593 is the S-enantiomer of BAY-593 (HY-161573). BAY-593 is an orally active GGTase-I inhibitor. BAY-593 can block YAP1/TAZ signaling in animals and has antitumor activity .
|
-
-
- HY-15427B
-
|
|
Btk
|
Others
|
|
GDC-0834 (S-enantiomer) is the S-enantiomer of GDC-0834. GDC-0834 is a potent and selective BTK inhibitor.
|
-
-
- HY-14566A
-
-
-
- HY-19433A
-
|
|
iGluR
|
Neurological Disease
|
|
(S)-ATPO is the (S)-enantiomer of ATPO, which is a competitive antagonist at GluR1-4 (AMPA-preferring) receptors .
|
-
-
- HY-148807B
-
|
(S)-QC8222 free base; (S)-TACH 101 free base
|
Histone Demethylase
|
Others
|
|
(S)-Zavondemstat is the S-enantiomer of Zavondemstat (HY-148807). Zavondemstat is an inhibitor of histone lysine demethylase 4D (KDM4D) with antineoplastic activity [1] .
|
-
-
- HY-13749C
-
|
(S)-MK-0431 phosphate
|
Dipeptidyl Peptidase
Autophagy
|
Metabolic Disease
|
|
(S)-Sitagliptin phosphate is the less active S-enantiomer of Sitagliptin phosphate. Sitagliptin phosphate (MK-0431 phosphate) is a potent inhibitor of DPP4 with an IC50 of 19 nM in Caco-2 cell extracts .
|
-
-
- HY-12872B
-
|
EGF816 (S-enantiomer)
|
EGFR
|
Others
|
|
Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor.
|
-
-
- HY-B0432B
-
|
(S)-SA-79
|
Sodium Channel
|
Cardiovascular Disease
|
|
(S)-Propafenone ((S)-SA-79) is the S-enantiomer of Propafenone. (S)-Propafenone ((S)-SA-79) exerts beta-blocking action and the sodium channel-dependent antiarrhythmic class 1 activity .
|
-
-
- HY-12560D
-
|
|
nAChR
|
Others
|
|
PNU-282987 S enantiomer free base is the S-enantiomer of PNU-282987 free base. PNU-282987 is an α7 nicotinic acetylcholine receptor (α7 nAChR) agonist.
|
-
-
- HY-N2037B
-
|
(S)-Norcoclaurine
|
Endogenous Metabolite
|
Others
|
|
(S)-Higenamine ((S)-Norcoclaurine), a S-enantiomer of Higenamine, is the entry compound in benzylisoquinoline alkaloid biosynthesis. (S)-Higenamine is produced by the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) by norcoclaurine synthase (NCS) .
|
-
-
- HY-19545B
-
|
SCH-23388 hydrochloride
|
Dopamine Receptor
|
Neurological Disease
|
|
(S)-SCH-23390 hydrochloride is the S-enantiomer of SCH-23390 (HY-19545). SCH-23390 is a dopamine D1-like receptor antagonist (with Ki values of 0.2 nM and 0.3 nM for the D1 and D5 receptor subtypes, respectively) .
|
-
-
- HY-115688A
-
|
|
Arrestin
|
Cardiovascular Disease
Others
|
|
(S)-TXNIP-IN-1 is the less active S-enantiomer of TXNIP-IN-1 (HY-115688). TXNIP-IN-1 is a TXNIP-TRX complex inhibitor which can be used in the research of TXNIP-TRX complex associated metabolic disorder (diabetes), cardiovascular disease, or inflammatory disease
|
-
-
- HY-B0352A
-
|
(S)-Org3770; (S)-6-Azamianserin
|
5-HT Receptor
|
Neurological Disease
|
|
(S)-Mirtazapine ((S)-Org3770) is a S(+)-enantiomer of Mirtazapine with pronociceptive properties in an animal model of acute thermal nociception. (S)-Mirtazapine is a stereoselective 5-HT2 receptor antagonist. (S)-Mirtazapine is metabolized by CYP2D6 and CYP1A2 .
|
-
-
- HY-13788A
-
|
|
5-HT Receptor
|
Others
|
|
LY 344864 S-enantiomer is the S-enantiomer of LY344864. LY344864 is a 5-HT1F receptor agonist.
|
-
-
- HY-B0612E
-
|
|
Calcium Channel
|
Cardiovascular Disease
|
|
(S)-Lercanidipine hydrochloride is the S-enantiomer of Lercanidipine hydrochloride. (S)-lercanidipine hydrochloride is a potent calcium channel blocker .
|
-
-
- HY-N4200
-
-
-
- HY-147041A
-
|
(2S)-GB1211
|
Galectin
|
Cancer
|
|
(2S)-Selvigaltin is the S-enantiomer of Selvigaltin (HY-147041). Selvigaltin is an orally active galectin-3 (Gal-3) inhibitor .
|
-
-
- HY-14551B
-
|
(S)-SR142801
|
Neurotensin Receptor
|
Neurological Disease
|
|
(S)-Osanetant is the S-enantiomer of Osanetant. Osanetant (SR142801) is a selective NK3 receptor antagonist. Osanetant produces anxiolytic- and antidepressant-like effects and is researched for schizophrenia .
|
-
-
- HY-171032A
-
-
-
- HY-E70239A
-
|
|
Drug Isomer
|
Metabolic Disease
|
|
(S)-2-Methylbutyryl-CoA tetrasodium is a S-enantiomer of 2-Methylbutyryl-CoA (HY-E70239). 2-Methylbutyryl-CoA is an intermediate of isoleucine metabolism .
|
-
-
- HY-B1059S
-
-
-
- HY-131284
-
|
|
Drug Metabolite
|
Others
|
|
(S)-Dehydro Venlafaxine is an inactive S-enantiomer of Dehydro Venlafaxine. Dehydro Venlafaxine is an impurity of Venlafaxine hydrochloride. Venlafaxine hydrochloride (Wy 45030 hydrochloride) is a potent serotonin (5-HT) / norepinephrine (NE) reuptake dual inhibitor .
|
-
-
- HY-147306A
-
|
|
NO Synthase
|
Neurological Disease
|
|
(S)-ZLc002 is a S-enantiomer of ZLc-002. ZLc-002 is a selective inhibitor of nNOS-Capon coupling. ZLc-002 suppresses inflammatory nociception and chemotherapy-induced neuropathic pain .
|
-
-
- HY-CE00185
-
|
(2S)-Methylmalonyl-coenzyme A
|
Biochemical Assay Reagents
|
Others
|
|
(2S)-Methylmalonyl-CoA ((2S)-Methylmalonyl-coenzyme A) is the (S)-enantiomer of Methylmalonyl-CoA (HY-126791). Methylmalonyl coenzyme A (Methylmalonyl-CoA) is a catabolite of valine, isoleucine, methionine, threonine, odd-chain fatty acids, and cholesterol.
|
-
-
- HY-128856
-
|
|
Drug Derivative
|
Neurological Disease
|
|
P7C3-OMe is a pro-neurogenic compound, has therapeutic benefits in neuropsychiatric and/or neurodegenerative disease. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer .
|
-
- HY-121203S4
-
|
|
Serotonin Transporter
Isotope-Labeled Compounds
|
Neurological Disease
Cancer
|
|
Citalopram-d3 hydrochloride is deuterated labeled Citalopram (HY-121203). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
|
-
- HY-112164B
-
|
IDO/TDO Inhibitor (S-enantiomer)
|
Indoleamine 2,3-Dioxygenase (IDO)
|
Cancer
|
|
IACS-8968 (S-enantiomer) is the S-enantiomer of IACS-8968. IACS-8968 is a dual IDO and TDO inhibitor, with pIC50s of 6.43 for IDO and <5 for TDO, respectively.
|
-
- HY-145572B
-
|
(S)-LY-3484356 tosylate
|
Drug Isomer
|
Cancer
|
|
(S)-Imlunestrant ((S)-LY-3484356) tosylate is an (S)-enantiomer of Imlunestrant (HY-145572). (S)-Imlunestrant tosylate can be used in research of cancer .
|
-
- HY-106577A
-
|
Escibenzoline; (-)-(S)-Cifenline; (-)-(S)-Ro 22-7796
|
Potassium Channel
|
Metabolic Disease
|
|
(-)-(S)-Cibenzoline (Escibenzoline), a S(+)-enantiomer of Cibenzoline, is an antiarrhythmic agent .
|
-
- HY-129231
-
-
- HY-12421B
-
-
- HY-117488
-
|
(S)-OPC-17116; (S)-dl-Grepafloxacin
|
Bacterial
|
Infection
|
|
(S)-Grepafloxacin ((S)-OPC-17116) is the S-enantiomer of Grepafloxacin (HY-A0147) .
|
-
- HY-122891A
-
|
|
PI3K
|
Cancer
|
|
(2S)-SB02024 (SB02877), the S-enantiomer of SB02024 (HY-122891), is a Vps34 inhibitor .
|
-
- HY-139534A
-
|
|
Drug Isomer
|
Others
|
|
(S)-ARI-1 is an S-enantiomer of ARI-1. ARI-1 is a ROR1 inhibitor and apoptosis inducer, used in NSCLC research .
|
-
- HY-W040193B
-
|
(S)-1,2-Distearoyl-sn-glycero-3-PC; (S)-1,2-Distearoyl-sn-glycero-3-phosphorylcholine
|
Liposome
|
Others
|
|
(S)-DSPC ((S)-1,2-Distearoyl-sn-glycero-3-PC) is a (S)-enantiomer of DSPC (HY-W040193).
|
-
- HY-107661A
-
|
(S)ONO-2506; (S)-2-Propyloctanoic acid
|
Drug Isomer
|
Others
|
|
S-(+)-Arundic Acid ((S)ONO-2506) is the S-enantiomer of Arundic Acid. Arundic acid is an astrocyte-modulating agent, has the potential for stroke and Alzheimer’s disease research .
|
-
- HY-160144S1
-
|
(S)-BMS-986322
|
JAK
|
Inflammation/Immunology
|
|
(S)-Lomedeucitinib ((S)-BMS-986322) is a S-enantiomer of Lomedeucitinib (HY-160144S). Lomedeucitinib is a tyrosine protein kinase (TYK2) inhibitor .
|
-
- HY-106577AS
-
|
Escibenzoline-d4; (-)-(S)-Cifenline-d4; (-)-(S)-Ro 22-7796-d4
|
Isotope-Labeled Compounds
Potassium Channel
|
Metabolic Disease
|
|
(-)-(S)-Cibenzoline-d4 (Escibenzoline-d4) is deuterium labeled (-)-(S)-Cibenzoline. (-)-(S)-Cibenzoline (Escibenzoline), a S(+)-enantiomer of Cibenzoline, is an antiarrhythmic agent .
|
-
- HY-157641A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
(2S)-18:1 Lyso PC is the (2S)-enantiomer of lysophosphatidylcholine (Lyso PC). LysoPC is a class of phospholipids, which are essential components of cell membranes.
|
-
- HY-14299B
-
|
|
Adrenergic Receptor
|
Others
|
|
(S)-Indacaterol is the S-enantiomer of Indacaterol (HY-14299). Indacaterol is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist .
|
-
- HY-124281A
-
|
|
Drug Isomer
NF-κB
|
Others
|
|
9(S)-PAHSA is a S-enantiomer of 9-PAHSA. 9-PAHSA is an orally available anti-inflammatory lipid that lowers blood sugar and reduces inflammation .
|
-
- HY-145835A
-
|
|
PERK
|
Infection
Cancer
|
|
(S)-PERK-IN-5 is the S-enantiomer of PERK-IN-5. (S)-PERK-IN-5 (example 39) is a PERK inhibitor, with an IC50 of 0.101-0.250 μM .
|
-
- HY-10399B
-
|
TV-3279
|
Cholinesterase (ChE)
|
Neurological Disease
|
|
(S)-Ladostigil (TV-3279), the S-enantiomer of TV 3326 (HY-10399), is a ChE inhibitor with poor MAO-B inhibitory activity. (S)-Ladostigil has neuroprotective effect
|
-
- HY-W214058
-
|
(S)-N-Acetyl-2-naphthylalanine
|
Biochemical Assay Reagents
|
Others
|
|
Ac-2-Nal-OH ((S)-N-Acetyl-2-naphthylalanine), the S-enantiomer of N-Acetyl-2-naphthylalanine, is used as a biochemical assay reagent .
|
-
- HY-155453
-
|
|
Biochemical Assay Reagents
|
Others
|
|
IB87 is an amine nicotine hapten. IB87 contains a linker e attached to the 6-position of (S)-enantiomer of nicotine. IB87 conjugates to KLH via carbodiimide-mediated reactions .
|
-
- HY-162110A
-
-
- HY-B0106AS
-
-
- HY-B1059R
-
-
- HY-109004A
-
|
(S)-BTA-C585
|
RSV
|
Cancer
|
|
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77) .
|
-
- HY-153306A
-
|
(S)-RLY-2608
|
PI3K
Drug Isomer
|
Cancer
|
|
(S)-Zovegalisib ((S)-RLY-2608) is an S-enantiomer of of Zovegalisib (HY-153306). Zovegalisib is an orally active first-in-class allosteric mutant-selective inhibitor of PI3Ka with anti-tumor activity .
|
-
- HY-B0602D
-
|
|
Drug Metabolite
|
Neurological Disease
|
|
(S)-(+)-O-Desmethyl Venlafaxine is a S-enantiomer of O-Desmethyl Venlafaxine. O-Desmethyl Venlafaxine is an active metabolite of Venlafaxine . Venlafaxine (HY-B0196) is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class .
|
-
- HY-103560
-
|
|
mGluR
|
Neurological Disease
|
|
(S)-HexylHIBO is the S-enantiomer of HexylHIBO. HexylHIBO is a group I mGluR antagonist. HexylHIBO elevates the hypothalamus-pituitary-adrenal axis response to restraint in rats. HexylHIBO is promising for research of central nervous system-related diseases .
|
-
- HY-14200A
-
|
TVP1022 mesylate; S-PAI mesylate
|
Monoamine Oxidase
|
Neurological Disease
|
|
(S)-Rasagiline (TVP1022) mesylate is the relatively inactive S-enantiomer form of Rasagiline mesylate. Rasagiline mesylate is a highly potent selective irreversible MAO inhibitor with IC50s of 4.43 nM and 412 nM for rat brain MAO B and A activity, respectively .
|
-
- HY-14855AR
-
|
(S)-TR 700 (Standard); (S)-DA 7157 (Standard)
|
Reference Standards
Bacterial
Antibiotic
|
Infection
|
|
(S)-Tedizolid (Standard) is the analytical standard of (S)-Tedizolid. This product is intended for research and analytical applications. (S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. (S)-Tedizolid is the less active isomer.
|
-
- HY-B0106AR
-
|
UCB 6474 (Standard)
|
Reference Standards
Calcium Channel
|
Neurological Disease
|
|
Etiracetam (Standard) is the analytical standard of Etiracetam. This product is intended for research and analytical applications. Etiracetam (UCB 6474) is an acetylcholine agonist and a nootropic drug of the racetam family. Less active than its S-enantiomer Levetiracetam (UCB L059) .
|
-
- HY-163103
-
|
|
Drug Isomer
|
Inflammation/Immunology
|
|
(S)-Isomyosmine is the S-enantiomer of Isomyosmine (HY-W701069). Isomyosmine is a nitrate reductase inhibitor. Isomyosmine is a nicotine related alkaloid present in solanecea plants containing nicotine. Isomyosmine can be used for research of inflammation and age-related disorders .
|
-
- HY-139355
-
|
|
SARS-CoV
|
Infection
|
|
(S)-GS-621763 is the S-enantiomer of GS-621763 (HY-145119). GS-621763 is an orally active prodrug form of GS-443902 (HY-126303) that inhibits SARS-CoV-2 .
|
-
- HY-10011A
-
|
|
CXCR
|
Inflammation/Immunology
Endocrinology
|
|
(S)-SCH 563705 is a S-enantiomer of SCH 563705. SCH 563705 (compound 16) is a potent and orally available CXCR2 and CXCR1 antagonist, with IC50s of 1.3 nM, 7.3 nM and Kis of 1 and 3 nM, respectively .
|
-
- HY-12210
-
|
|
HIV Integrase
|
Infection
|
|
(S)-BI-1001 (Compound 11) is an active S-enantiomer of BI-1001. (S)-BI-1001 exhibits antiviral potency against HIV-1 integrase with an IC50 of 28 nM, an EC50 of 450 nM and a Kd of 4.7 μM .
|
-
- HY-B0006BS
-
-
- HY-13749CR
-
|
(S)-MK-0431 phosphate (Standard)
|
Reference Standards
Dipeptidyl Peptidase
Autophagy
|
Metabolic Disease
|
|
(S)-Sitagliptin (phosphate) (Standard) is the analytical standard of (S)-Sitagliptin (phosphate). This product is intended for research and analytical applications. (S)-Sitagliptin phosphate is the less active S-enantiomer of Sitagliptin phosphate. Sitagliptin phosphate (MK-0431 phosphate) is a potent inhibitor of DPP4 with an IC50 of 19 nM in Caco-2 cell extracts .
|
-
- HY-121203R
-
|
|
Reference Standards
Serotonin Transporter
|
Neurological Disease
Cancer
|
|
Citalopram (Standard) is the analytical standard of Citalopram. This product is intended for research and analytical applications. Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
|
-
- HY-184117
-
|
|
Ser/Thr Protease
|
Others
|
|
pMeO-Bz-SF is a covalent, stereoselective α-chymotrypsin inhibitor with an IC50 value of 133 nM. The (R)-enantiomer of pMeO-Bz-SF inhibits α-chymotrypsin with an IC50 of 101 nM. The (S)-enantiomer of pMeO-Bz-SF shows low activity against α-chymotrypsin, with an IC50 of 2965 nM .
|
-
- HY-147327A
-
|
NSC 37024
|
Biochemical Assay Reagents
|
Cancer
|
|
(S)-N-Formylsarcolysine is the (S)-enantiomer of N-Formylsarcolysine. N-Formylsarcolysine can be studied on its antitumor acitivity .
|
-
- HY-186169A
-
-
- HY-E71116
-
|
|
Biochemical Assay Reagents
|
Others
|
|
(S)-Carnitine 3-dehydrogenase (EC 1.1.1.254) is specific for the (S)-enantiomer of carnitine, i.e., the enantiomer of the substrate of carnitine 3-dehydrogenase
|
-
- HY-E70239B
-
|
|
Drug Isomer
|
Metabolic Disease
|
|
(S)-2-Methylbutyryl-CoA sodium is a S-enantiomer of 2-Methylbutyryl-CoA (HY-E70239). 2-Methylbutyryl-CoA is an intermediate of isoleucine metabolism .
|
-
- HY-N7739
-
|
|
Insecticide
Sex Pheromone
|
Infection
|
|
Lavandulyl senecioate is a senecioyl ester of lavandulol.Lavandulyl senecioate’s (S)-enantiomer serves as the sex pheromone of the vine mealybug (Planococcus ficus). Lavandulyl senecioate can be used in research related to pest control .
|
-
- HY-158208A
-
|
|
Apoptosis
|
Cancer
|
|
(1S)-PMMB276 is the (1S)-enantiomer of PMMB276 (HY-158208). PMMB276 is a potent inhibitor of β-tubulin isotype III (Tubb3) polymerization and induced apoptosis .
|
-
- HY-12584A
-
|
(S)-PF-05190457
|
GHSR
|
Metabolic Disease
|
|
(S)-PF-5190457 ((S)-PF-05190457) is the S-enantiomer of PF-5190457 (HY-12584). PF-5190457 (PF-05190457) is a potent and selective ghrelin receptor inverse agonist with a pKi of 8.36 .
|
-
- HY-120627
-
|
|
5-HT Receptor
|
Neurological Disease
|
|
BMS-442606, the S-enantiomer of 6-hydroxybuspirone (6OHB), is an orally active 5-HT1A partial agonist. BMS-442606 can be used for generalized anxiety disorder (GAD) research .
|
-
- HY-12520C
-
|
|
Drug Isomer
Dopamine Receptor
|
Neurological Disease
|
|
(S)-SKF 38393 (Compound 7) is the S-enantiomer of SKF 38393 (HY-12520). (S)-SKF 38393 shows no activity against the D1 dopamine receptor, with an IC50 of 10700 nM. (S)-SKF 38393 can be used in the research of neurological diseases .
|
-
- HY-138439
-
|
|
Fungal
Mitochondrial Metabolism
|
Infection
|
|
Mandestrobin is a fungicide that exerts fungal killing activity by inhibiting mitochondrial respiratory chain complex III. Mandestrobin exhibits differential fungicidal activity between its enantiomers, and the R-enantiomer possesses stronger activity than the S-enantiomer. Mandestrobin is used in studies related to fungal infections and the agricultural field .
|
-
- HY-12386A
-
|
|
Drug Intermediate
|
Others
|
|
(S)-4-(3-Thienyl) phenyl-α-methylacetic acid is the S-enantiomer of the racemate corresponding to 4-(3-Thienyl) phenyl-α-methylacetic acid. As a key synthetic precursor, 4-(3-Thienyl) phenyl-α-methylacetic acid is used to prepare the cyclooxygenase inhibitor S-Atliprofen .
|
-
- HY-121203S6
-
|
|
Isotope-Labeled Compounds
Serotonin Transporter
|
Neurological Disease
Cancer
|
|
Citalopram-d4 (oxalate) is the deuterium labeled Citalopram oxalate (HY-121203A). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
|
-
- HY-78131AS
-
|
(S)-Ibuprofen d3
|
COX
|
Inflammation/Immunology
|
|
(S)-(+)-Ibuprofen-d3 is a deuterium labeled (S)-(+)-Ibuprofen. (S)-(+)-Ibuprofen is the S(+)-enantiomer of Ibuprofen that inhibits COX-1 and COX-2 activity with IC50s of 2.1 μM and 1.6 μM. (S)-(+)-Ibuprofen has analgesic, antiinflammatory and antipyretic effects .
|
-
- HY-139727A
-
|
|
Adrenergic Receptor
|
Cardiovascular Disease
|
|
S(-)-Bisoprolol fumarate is a S(-)-enantiomer of Bisoprolol fumarate. Bisoprolol fumarate is a potent, selective and orally active β1-adrenergic receptor blocker. Bisoprolol has little activity on β2-receptor and has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research .
|
-
- HY-139727
-
|
|
Adrenergic Receptor
|
Cardiovascular Disease
|
|
S(-)-Bisoprolol is a S(-)-enantiomer of Bisoprolol. Bisoprolol is a potent, selective and orally active β1-adrenergic receptor blocker. Bisoprolol has little activity on β2-receptor and has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research .
|
-
- HY-W018499R
-
|
|
Reference Standards
Endogenous Metabolite
|
Others
|
|
(S)-2-Hydroxybutanoic acid (Standard) is the analytical standard of (S)-2-Hydroxybutanoic acid. This product is intended for research and analytical applications. (S)-2-Hydroxybutanoic acid is the S-enantiomer of 2-Hydroxybutanoic acid. 2-Hydroxybutanoic acid, a coproduct of protein metabolism, is an insulin resistance (IR) biomarker[1].
|
-
- HY-108610C
-
|
(S)-ET-18-OCH3
|
Apoptosis
|
Cancer
|
|
(S)-Edelfosine ((S)-ET-18-OCH3) is the (S)-enantiomer of Edelfosine (ET-18-OCH3) (HY-108610C). Edelfosine is a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 Death receptor .
|
-
- HY-76476
-
|
(+)-3-Hydroxytetrahydrofuran
|
Biochemical Assay Reagents
|
Others
|
|
(S)-Tetrahydrofuran-3-ol is a (S)-enantiomer of Tetrahydrofuran-3-ol. Tetrahydrofuran-3-ol is an important precursor for the production of HIV protease inhibitors. Tetrahydrofuran-3-ol can be produced via chemical synthesis or by enzymatic hydrolysis of bulkier esters and inversion of the unwanted product .
|
-
- HY-14258
-
Escitalopram
Maximum Cited Publications
11 Publications Verification
(S)-Citalopram; (S)-(+)-Citalopram
|
Serotonin Transporter
|
Neurological Disease
|
|
Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ∼30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression .
|
-
- HY-B0352AS
-
|
(S)-Org3770 d3; (S)-6-Azamianserin d3
|
5-HT Receptor
|
Neurological Disease
|
|
(S)-Mirtazapine-d3 is a deuterium labeled (S)-Mirtazapine. (S)-Mirtazapine is a S(+)-enantiomer of Mirtazapine with pronociceptive properties in an animal model of acute thermal nociception.(S)-Mirtazapine is a stereoselective 5-HT2 receptor antagonist. (S)-Mirtazapine is metabolized by CYP2D6 and CYP1A2[1].
|
-
- HY-14258A
-
|
(S)-Citalopram oxalate; (S)-(+)-Citalopram oxalate
|
Serotonin Transporter
|
Neurological Disease
Cancer
|
|
Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ∼30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression .
|
-
- HY-109004AR
-
|
(S)-BTA-C585 (Standard)
|
Reference Standards
RSV
|
Cancer
|
|
(S)-Enzaplatovir (Standard) is the analytical standard of (S)-Enzaplatovir (HY-109004A). This product is intended for research and analytical applications. (S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77) .
|
-
- HY-186079A
-
|
|
Drug Isomer
Integrin
|
Inflammation/Immunology
|
|
(S)-Deethyl-emvistegrast is the S-enantiomer of Deethyl-emvistegrast (HY-186079). Deethyl-emvistegrast is a quinoline derivative and also a α4β7 integrin inhibitor. It acts as the hydrolysis product of Emvistegrast (HY-177080). Deethyl-emvistegrast modulates inflammatory pathways and can be used in research related to inflammatory bowel diseases (Crohn's disease and ulcerative colitis) .
|
-
- HY-176444B
-
|
|
CDK
Molecular Glues
|
Cancer
|
|
(S)-CDK2 degrader 6 (Compound 8) is the S-enantiomer of CDK2 degrader 6 (HY-176444). (S)-CDK2 degrader 6 is a selective CDK2 molecular glue degrader with a DC50 of 166.7 nM in 24 h. (S)-CDK2 degrader 6 can be used for breast cancer research .
|
-
- HY-78131AR
-
|
Dexibuprofen (Standard)
|
Reference Standards
COX
|
Inflammation/Immunology
|
|
(S)-(+)-Ibuprofen (Standard) is the analytical standard of (S)-(+)-Ibuprofen. This product is intended for research and analytical applications. (S)-(+)-Ibuprofen ((S)-Ibuprofen), a S(+)-enantiomer of Ibuprofen, is a potent COX-1 and COX-2 inhibitor with IC50s of 2.1 μM and 1.6 μM, respectively. (S)-(+)-Ibuprofen has analgesic, anti-inflammatory, anticancer and antipyretic effects .
|
-
- HY-W700354
-
|
|
Calcium Channel
|
Cardiovascular Disease
Metabolic Disease
|
|
(S)-(-)-Felodipine is a S-enantiomer of Felodipine. (S)-(-)-Felodipine is an antihypertensive agent. Felodipine is a 1,4-dihydropyridine derivative and a vasoselective calcium antagonist. Felodipine can prevent the activation of the vascular effector cells and interfere with the contractile process in vitro. Felodipine lowers mean arterial blood pressure by 20% in dog model. (S)-(-)-Felodipine shows high metabolic rate in rat and dog liver microsomes .
|
-
- HY-14200
-
|
TVP1022; S-PAI
|
Monoamine Oxidase
|
Neurological Disease
|
|
(S)-Rasagiline (TVP1022) is the relatively inactive S-enantiomer form of Rasagiline. Rasagiline is a highly potent selective irreversible MAO inhibitor with IC50s of 4.43 nM and 412 nM for rat brain MAO B and A activity, respectively . (S)-Rasagiline is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-138257
-
|
(S)-AS1069562; (S)-YM-08054 benzenesulfonate
|
5-HT Receptor
|
Neurological Disease
|
|
(S)-AS1069562 is the S-enantiomer of AS1069562 (HY-138257A). AS1069562 is an orally active 5-HT and NE reuptake inhibitor, with IC50 values of 0.35 μM and 3.3 μM, respectively. AS1069562 possesses curative-like analgesic effect. AS1069562 might improve nerve function impairment via the amelioration of neurotrophic support .
|
-
- HY-W074930R
-
|
(S)-GS 1278 (Standard); (S)-PMPA (Standard); (S)-TDF (Standard)
|
Reference Standards
HIV
HBV
|
Infection
|
|
(S)-Tenofovir (Standard) is the analytical standard of (S)-Tenofovir. This product is intended for research and analytical applications. (S)-Tenofovir is the less active S-enantiomer of Tenofovir (HY-13910). Tenofovir is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV). (S)-Tenofovir has low activity to Orf virus. (S)-Tenofovir can be used for research on contagious pustular dermatitis .
|
-
- HY-14258R
-
|
(S)-Citalopram (Standard); (S)-(+)-Citalopram (Standard)
|
Serotonin Transporter
Reference Standards
|
Neurological Disease
Cancer
|
|
Escitalopram (Standard) is the analytical standard of Escitalopram. This product is intended for research and analytical applications. Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression .
|
-
- HY-122489A
-
|
|
Opioid Receptor
GABA Receptor
|
Cardiovascular Disease
Neurological Disease
|
|
(S)-Laudanosine is an alkaloid that can be found in poppies and is the S-enantiomer of Laudanosine. Laudanosine acts on the central nervous system and cardiovascular system, inhibiting low-affinity GABA receptors with an IC50 value of 10 μM, and can cause seizures, hypotension, and bradycardia. Additionally, Laudanosine exerts analgesic effects by competitively binding to the opioid Mu-1 receptor (Ki = 2.7 μM) .
|
-
- HY-15977
-
|
|
Drug Isomer
|
Neurological Disease
|
|
(S)-P7C3-OMe, P7C3-A20 hydroxylated analog, is the (S)-enantiomer of P7C3-OMe. P7C3-OMe is a pro-neurogenic compound, can be used for the research of neuropsychiatric and/or neurodegenerative disease .
|
-
- HY-14258AS
-
|
|
Serotonin Transporter
|
Neurological Disease
|
|
Escitalopram-d6 (oxalate) is the deuterium labeled Escitalopram oxalate. Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression .
|
-
- HY-148669B
-
|
(S)-JNJ-75276617 oxalate; (S)-Menin-MLL inhibitor 24 oxalate
|
Apoptosis
Histone Methyltransferase
FLT3
|
Cancer
|
|
(S)-Bleximenib (oxalate) is a S-Enantiomer of Bleximenib oxalate (HY-148669A). Bleximenib (JNJ-75276617) oxalate is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib oxalate can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib oxalate can be used in the research of tumors such as leukemia .
|
-
- HY-132842A
-
|
(S)-DZD9008
|
EGFR
Btk
|
Cancer
|
|
(S)-Sunvozertinib ((S)-DZD9008), the S-enantiomer of Sunvozertinib, shows inhibitory activity against EGFR exon 20 NPH and ASV insertions, EGFR L858R/T790M mutation and Her2 exon20 YVMA insertion (IC50=51.2 nM, 51.9 nM, 1 nM, and 21.2 nM, respectively). (S)-Sunvozertinib also inhibits BTK .
|
-
- HY-14258AS1
-
|
(S)-Citalopram-d4 oxalate; (S)-(+)-Citalopram-d4 oxalate
|
Isotope-Labeled Compounds
Serotonin Transporter
|
Neurological Disease
|
|
Escitalopram-d4 (oxalate) is deuterium labeled Escitalopram (oxalate). Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression .
|
-
- HY-14258AR
-
|
(S)-Citalopram oxalate (Standard); (S)-(+)-Citalopram oxalate (Standard)
|
Reference Standards
Serotonin Transporter
|
Neurological Disease
Cancer
|
|
Escitalopram (oxalate) (Standard) is the analytical standard of Escitalopram (oxalate). This product is intended for research and analytical applications. Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ∼30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression .
|
-
- HY-19202
-
|
rac-EMA401; rac-PD-126055; EMA400
|
Angiotensin Receptor
|
Neurological Disease
|
|
rac-Olodanrigan (rac-EMA401; EMA400) is a racemic mixture of the S-enantiomer (EMA401; HY-13106) and R-enantiomer (EMA402). rac-Olodanrigan is a potent and selective AT2 receptor antagonist with IC50s of 75.2 nM and 2918 nM for AT2R and AT1R, respectively. rac-Olodanrigan evokes dose-dependent relief of mechanical allodynia in the ipsilateral hind paws of rats with a chronic constriction injury (CCI) of the sciatic nerve .
|
-
- HY-109009A
-
|
(S)-UCB-0942
|
GABA Receptor
|
Neurological Disease
|
|
(S)-Padsevonil is the S-enantiomer of Padsevonil (HY-109009).Padsevonil (UCB0942) is a potent antiepileptic agent that selectively acts on presynaptic and postsynaptic targets. Padsevonil binds to synaptic vesicular protein 2 (SV2) with high affinity. Padsevonil is also a positive allosteric modulator and partial agonist of GABAAR, with high potency against α1 and α5 receptors. Padsevonil has antiepileptic effects in a variety of rodent models .
|
-
- HY-E71132
-
|
|
Biochemical Assay Reagents
|
Others
|
|
(S)-Sulfolactate dehydrogenase (EC 1.1.1.310) acts on the (S)-enantiomer of 3-sulfolactate. (S)-Sulfolactate dehydrogenase (EC 1.1.1.310) binds to (2R)-3-sulfolactate dehydrogenase (NADP+) to form a racemic enzyme system that converts (2S)-3-sulfolactate to (2R)-3-sulfolactate. (S)-Sulfolactate dehydrogenase (EC 1.1.1.310) is specific for NAD+.
|
-
- HY-76476R
-
|
(+)-3-Hydroxytetrahydrofuran (Standard)
|
Biochemical Assay Reagents
Reference Standards
|
Others
|
|
(S)-Tetrahydrofuran-3-ol (Standard) is the analytical standard of (S)-Tetrahydrofuran-3-ol. This product is intended for research and analytical applications. (S)-Tetrahydrofuran-3-ol is a (S)-enantiomer of Tetrahydrofuran-3-ol. Tetrahydrofuran-3-ol is an important precursor for the production of HIV protease inhibitors. Tetrahydrofuran-3-ol can be produced via chemical synthesis or by enzymatic hydrolysis of bulkier esters and inversion of the unwanted product .
|
-
- HY-16776A
-
|
(2S,5S)-Festinavir; (2S,5S)-BMS-986001; (2S,5S)-OBP-601
|
HIV
|
Infection
|
|
(2S,5S)-Censavudine ((2S,5S)-OBP-601) is the (2S,5S)-enantiomer of Censavudine. Censavudine, a nucleoside reverse transcriptase inhibitor, is a potent HIV inhibitor . (2S,5S)-Censavudine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-100218B
-
|
|
Glutathione Peroxidase
Ferroptosis
|
Cancer
|
|
(1R,3S)-RSL3 is the less active (1R,3S)-enantiomer of RSL3 ((1S,3R)-RSL3). (1R,3S)-RSL3 and RSL3 induce cell death in HT22 wild-type cells with EC50 values of 5.2 µM and 0.004 µM, rspectively .
|
-
- HY-100742BR
-
|
|
Lactate Dehydrogenase
Reference Standards
|
Cancer
|
|
(S)-GNE-140 (Standard) is the analytical standard of (S)-GNE-140 (HY-100742B). This product is intended for research and analytical applications. (S)-GNE-140 (Compound 30-S) is the S-enantiomer of GNE-140 (HY-118241). (S)-GNE-140 is an effective lactate dehydrogenase (LDH) inhibitor, with IC50 values of 55 nM for LDHA and 140 nM for LDHB. (S)-GNE-140 can be used in cancer research .
|
-
- HY-10450A
-
|
BMS-512148 (2S)-1,2-propanediol, hydrate
|
SGLT
|
Metabolic Disease
Cancer
|
|
Dapagliflozin ((2S)-1,2-propanediol, hydrate) is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin ((2S)-1,2-propanediol, hydrate) induces HIF1 expression and attenuates renal IR injury .
|
-
- HY-W021008
-
|
Dimethylhydroxyfuranone
|
Fungal
|
Infection
|
|
Sotolone (Dimethylhydroxyfuranone) is an activator of the human olfactory receptor OR8D1. Sotolone activates the human olfactory receptor OR8D1, with EC50 values of 84.98 μM and 167.2 μM for its S-enantiomer and R-enantiomer, respectively. Sotolone has unique aroma profiles: (R)-sotolone exhibits smoky, burnt, herbal and grassy notes; (S)-sotolone presents sweet, milky, sour and nutty notes. Sotolone also acts as an antifungal agent, showing moderate inhibitory activity against Magnaporthe oryzae in vitro .
|
-
- HY-B0371D
-
|
|
Adrenergic Receptor
|
Endocrinology
|
|
(S)-Terazosin is an active S-enantiomer of Terazosin. (S)-Terazosin is a potent and high-affinity α-adrenoceptor antagonist with Ki values of 3.91 nM, 0.79 nM and 1.16 nM for α1a, α1b and α1d-adrenoceptor, respectively. (S)-Terazosin also has high-affinity for α2a, α2B and α2c-adrenoceptor with Ki values of 729 nM, 3.5 nM and 46.4 nM, respectively .
|
-
- HY-109009AR
-
|
(S)-UCB-0942 (Standard)
|
Reference Standards
GABA Receptor
|
Neurological Disease
|
|
(S)-Padsevonil (Standard) is the analytical standard of (S)-Padsevonil (HY-109009A). This product is intended for research and analytical applications. (S)-Padsevonil is the S-enantiomer of Padsevonil (HY-109009).Padsevonil (UCB0942) is a potent antiepileptic agent that selectively acts on presynaptic and postsynaptic targets. Padsevonil binds to synaptic vesicular protein 2 (SV2) with high affinity. Padsevonil is also a positive allosteric modulator and partial agonist of GABAAR, with high potency against α1 and α5 receptors. Padsevonil has antiepileptic effects in a variety of rodent models .
|
-
- HY-121814A
-
|
(R)-Acenocoumarin; (R)-Nicoumalone
|
VD/VDR
|
Cardiovascular Disease
|
|
(R)-Acenocoumarol ((R)-Acenocoumarin; (R)-Nicoumalone) is a short-acting and orally active anticoagulant, like Warfarin (HY-B0687), works by inhibiting vitamin K epoxide reductase. (R)-Acenocoumarol has a greater in vivo anticoagulant potency than Warfarin. (R)-Acenocoumarol has a single chiral center that produces two different enantiomeric forms. (R)-Acenocoumarol has a longer plasma elimination half-life (6.6 h) and a slower plasma clearance rate (1.9 L/h) than the (S)-enantiomer, resulting in a stronger in vivo anticoagulant effect.
|
-
- HY-W021008S
-
|
Dimethylhydroxyfuranone-d2
|
Isotope-Labeled Compounds
Fungal
|
Infection
|
|
Sotolone-d2 (Dimethylhydroxyfuranone-d2) is deuterated labeled Sotolone. Sotolone is an activator of the human olfactory receptor OR8D1. Sotolone activates the human olfactory receptor OR8D1, with EC50 values of 84.98 μM and 167.2 μM for its S-enantiomer and R-enantiomer, respectively. Sotolone has unique aroma profiles: (R)-sotolone exhibits smoky, burnt, herbal and grassy notes; (S)-sotolone presents sweet, milky, sour and nutty notes. Sotolone also acts as an antifungal agent, showing moderate inhibitory activity against Magnaporthe oryzae in vitro .
|
-
- HY-120751A
-
|
|
Drug Isomer
Calcium Channel
|
Neurological Disease
|
|
(S)-TROX-1 is the S-enantiomer of TROX-1 (HY-120751). TROX-1 is a selective, orally active and brain-penetrant N-type calcium channel (Cav2.2) inhibitor with an IC50 value of 0.11 μM. TROX-1 exerts state-dependent and use-dependent inhibition, preferentially targets open/inactivated channels, blocks depolarization-associated calcium influx, and fully blocks calcium influx in rat dorsal root ganglion neurons. TROX-1 reverses inflammatory-induced hyperalgesia, nerve injury-induced allodynia. TROX-1 can be used for the research of pain .
|
-
- HY-W787758
-
|
4-yn-VPA
|
HDAC
P-glycoprotein
|
Neurological Disease
Cancer
|
|
2-Propylpent-4-ynoic acid (4-yn-VPA) is a HDAC inhibitor (with an IC50 of 0.5 mM against human HDAC). 2-Propylpent-4-ynoic acid also induces P-glycoprotein function, and exhibits teratogenicity, fetal growth inhibition and neurotoxicity. 2-Propylpent-4-ynoic acid shows significant stereospecific teratogenic effects, with the S-enantiomer being more teratogenic than the R-enantiomer and other analogs. The neurotoxicity of 2-Propylpent-4-ynoic acid is independent of its stereochemical structure. 2-Propylpent-4-ynoic acid has been used in studies related to the pathogenesis of colon cancer and neural tube defects such as exencephaly .
|
-
- HY-13636A
-
|
ICI 182780 (S enantiomer); ZD 9238 (S enantiomer); ZM 182780 (S enantiomer)
|
Drug Isomer
Estrogen Receptor/ERR
p38 MAPK
Apoptosis
|
Cancer
|
|
Fulvestrant (ICI 182780; ZD 9238) S enantiomer is the S-enantiomer of Fulvestrant (HY-13636), a potent estrogen receptor inhibitor. Fulvestrant binds to and blocks the estrogen receptor, promotes its degradation, and thereby inhibits receptor dimerization, nucleocytoplasmic shuttling and transcriptional activity. Fulvestrant effectively blocks estrogen signaling, MAPK pathway activation and ER-regulated protein expression. Fulvestrant induces apoptosis, inhibits the proliferation of breast cancer and prolactinoma cells, and reduces the mineralization level, alkaline phosphatase activity and osteocalcin expression of preosteoblasts. Prenatal exposure to Fulvestrant impairs ovarian follicular development and causes ovarian structural damage. Fulvestrant has been widely used in studies related to breast cancer, prolactinoma and other conditions .
|
-
- HY-10450AR
-
|
BMS-512148 (2S)-1,2-propanediol, hydrate (Standard)
|
Reference Standards
SGLT
|
Metabolic Disease
Cancer
|
|
Dapagliflozin ((2S)-1,2-propanediol, hydrate) (Standard) is the analytical standard of Dapagliflozin ((2S)-1,2-propanediol, hydrate). This product is intended for research and analytical applications. Dapagliflozin ((2S)-1,2-propanediol, hydrate) is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin ((2S)-1,2-propanediol, hydrate) induces HIF1 expression and attenuates renal IR injury .
|
-
- HY-15193B
-
|
|
SGK
Drug Isomer
|
Cardiovascular Disease
Cancer
|
|
EMD638683 (S-Form) (Compound 1a), the S-enantiomer of EMD638683 (HY-15193), is a SGK1 inhibitor with an IC50 value > 300 nM. EMD638683 is an orally active SGK1 inhibitor with an IC50 of 3 μM. EMD638683 exhibits strong inhibition against SGK1, moderate inhibition against SGK2 and SGK3, and shows excellent selectivity for other AGC kinase family members. EMD638683 has antihypertensive activity by inhibiting SGK1, and independently of the blood pressure-lowering effect, it effectively prevents heart inflammation and fibrosis caused by hypertension by inhibiting the cardiac NLRP3 inflammation body/ IL-1β axis. EMD638683 promotes apoptosis of colon cancer cells and sensitizes radiotherapy. EMD638683 (S-Form) can be used in research related to hypertension, hypertensive heart damage, and colon cancer .
|
-
- HY-175282A
-
|
|
Apoptosis
Caspase
CDK
PARP
Autophagy
|
Cancer
|
|
(2S,3R,4S)-ASX-173 is the (2S,3R,4S)-enantiomer of ASX-173 (HY-175282). ASX-173 is an orally active inhibitor of asparagine synthetase (ASNS) (IC50 = 0.113 μM, Ki = 0.4 nM). ASX-173 enhances the anticancer activity of L-asparaginase (ASNase) (HY-P1923). ASX-173 disrupts nucleotide synthesis and induces leukemia cell cycle arrest, apoptosis and autophagy in leukemia cells in combination with ASNase. ASX-173 slows the growth of OCI-AML2 xenografts in combination with ASNase. ASX-173 is indicated for the study of acute lymphoblastic leukemia, acute myeloid leukemia, colorectal cancer, and other cancers .
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-Y0816
-
|
|
Biochemical Assay Reagents
|
|
(S)-Mandelic Acid is a (S)-enantiomer of Mandelic Acid (HY-W015591). (S)-Mandelic Acid undergoes one-directional chiral inversion to (R)-Mandelic Acid in rat models. (S)-Mandelic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
|
-
- HY-76476
-
|
(+)-3-Hydroxytetrahydrofuran
|
Biochemical Assay Reagents
|
|
(S)-Tetrahydrofuran-3-ol is a (S)-enantiomer of Tetrahydrofuran-3-ol. Tetrahydrofuran-3-ol is an important precursor for the production of HIV protease inhibitors. Tetrahydrofuran-3-ol can be produced via chemical synthesis or by enzymatic hydrolysis of bulkier esters and inversion of the unwanted product .
|
-
- HY-76476R
-
|
(+)-3-Hydroxytetrahydrofuran (Standard)
|
Biochemical Assay Reagents
|
|
(S)-Tetrahydrofuran-3-ol (Standard) is the analytical standard of (S)-Tetrahydrofuran-3-ol. This product is intended for research and analytical applications. (S)-Tetrahydrofuran-3-ol is a (S)-enantiomer of Tetrahydrofuran-3-ol. Tetrahydrofuran-3-ol is an important precursor for the production of HIV protease inhibitors. Tetrahydrofuran-3-ol can be produced via chemical synthesis or by enzymatic hydrolysis of bulkier esters and inversion of the unwanted product .
|
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-W214058
-
|
(S)-N-Acetyl-2-naphthylalanine
|
Biochemical Assay Reagents
|
Others
|
|
Ac-2-Nal-OH ((S)-N-Acetyl-2-naphthylalanine), the S-enantiomer of N-Acetyl-2-naphthylalanine, is used as a biochemical assay reagent .
|
| Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
-
- HY-14258
-
Escitalopram
Maximum Cited Publications
11 Publications Verification
(S)-Citalopram; (S)-(+)-Citalopram
|
Natural Products
Endogenous metabolite
Source Classification
|
Serotonin Transporter
|
|
Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ∼30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression .
|
-
-
- HY-W018499
-
-
-
- HY-N2037C
-
-
-
- HY-N2037B
-
-
-
- HY-N4200
-
-
-
- HY-122489A
-
|
|
Alkaloids
Microorganisms
Isoquinoline Alkaloids
Source Classification
|
Opioid Receptor
GABA Receptor
|
|
(S)-Laudanosine is an alkaloid that can be found in poppies and is the S-enantiomer of Laudanosine. Laudanosine acts on the central nervous system and cardiovascular system, inhibiting low-affinity GABA receptors with an IC50 value of 10 μM, and can cause seizures, hypotension, and bradycardia. Additionally, Laudanosine exerts analgesic effects by competitively binding to the opioid Mu-1 receptor (Ki = 2.7 μM) .
|
-
-
- HY-W040193B
-
|
(S)-1,2-Distearoyl-sn-glycero-3-PC; (S)-1,2-Distearoyl-sn-glycero-3-phosphorylcholine
|
Lipid
|
Liposome
|
|
(S)-DSPC ((S)-1,2-Distearoyl-sn-glycero-3-PC) is a (S)-enantiomer of DSPC (HY-W040193).
|
-
-
- HY-157641A
-
|
|
Lipid
|
Biochemical Assay Reagents
|
|
(2S)-18:1 Lyso PC is the (2S)-enantiomer of lysophosphatidylcholine (Lyso PC). LysoPC is a class of phospholipids, which are essential components of cell membranes.
|
-
-
- HY-W018499R
-
-
-
- HY-14258R
-
|
(S)-Citalopram (Standard); (S)-(+)-Citalopram (Standard)
|
Structural Classification
Natural Products
Endogenous metabolite
Source Classification
|
Serotonin Transporter
Reference Standards
|
|
Escitalopram (Standard) is the analytical standard of Escitalopram. This product is intended for research and analytical applications. Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression .
|
-
-
- HY-N7739
-
-
-
- HY-W021008
-
|
Dimethylhydroxyfuranone
|
Structural Classification
Natural Products
Grona styracifolia (Osbeck) H. Ohashi & K. Ohashi
Plants
Fabaceae
Source Classification
|
Fungal
|
|
Sotolone (Dimethylhydroxyfuranone) is an activator of the human olfactory receptor OR8D1. Sotolone activates the human olfactory receptor OR8D1, with EC50 values of 84.98 μM and 167.2 μM for its S-enantiomer and R-enantiomer, respectively. Sotolone has unique aroma profiles: (R)-sotolone exhibits smoky, burnt, herbal and grassy notes; (S)-sotolone presents sweet, milky, sour and nutty notes. Sotolone also acts as an antifungal agent, showing moderate inhibitory activity against Magnaporthe oryzae in vitro .
|
-
| Cat. No. |
Product Name |
Chemical Structure |
-
- HY-78131AS
-
|
|
|
(S)-(+)-Ibuprofen-d3 is a deuterium labeled (S)-(+)-Ibuprofen. (S)-(+)-Ibuprofen is the S(+)-enantiomer of Ibuprofen that inhibits COX-1 and COX-2 activity with IC50s of 2.1 μM and 1.6 μM. (S)-(+)-Ibuprofen has analgesic, antiinflammatory and antipyretic effects .
|
-
-
- HY-14258AS
-
|
|
|
Escitalopram-d6 (oxalate) is the deuterium labeled Escitalopram oxalate. Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression .
|
-
-
- HY-B1059S
-
|
|
|
Levosulpiride-d3 is the deuterium labeled Levosulpiride. Levosulpiride (RV-12309) is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic agent of the benzamide class .
|
-
-
- HY-121203S4
-
|
|
|
Citalopram-d3 hydrochloride is deuterated labeled Citalopram (HY-121203). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
|
-
-
- HY-14258AS1
-
|
|
|
Escitalopram-d4 (oxalate) is deuterium labeled Escitalopram (oxalate). Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression .
|
-
-
- HY-160144S1
-
|
|
|
(S)-Lomedeucitinib ((S)-BMS-986322) is a S-enantiomer of Lomedeucitinib (HY-160144S). Lomedeucitinib is a tyrosine protein kinase (TYK2) inhibitor .
|
-
-
- HY-106577AS
-
|
|
|
(-)-(S)-Cibenzoline-d4 (Escibenzoline-d4) is deuterium labeled (-)-(S)-Cibenzoline. (-)-(S)-Cibenzoline (Escibenzoline), a S(+)-enantiomer of Cibenzoline, is an antiarrhythmic agent .
|
-
-
- HY-B0106AS
-
|
|
|
Etiracetam-d3 is the deuterium labeled Etiracetam. Etiracetam (UCB 6474) is an acetylcholine agonist and a nootropic drug of the racetam family. Less active than its S-enantiomer Levetiracetam (UCB L059) .
|
-
-
- HY-B0006BS
-
|
|
|
(S)-Carvedilol-d4 is deuterium labeled (S)-Carvedilol. (S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX) .
|
-
-
- HY-B0352AS
-
|
|
|
(S)-Mirtazapine-d3 is a deuterium labeled (S)-Mirtazapine. (S)-Mirtazapine is a S(+)-enantiomer of Mirtazapine with pronociceptive properties in an animal model of acute thermal nociception.(S)-Mirtazapine is a stereoselective 5-HT2 receptor antagonist. (S)-Mirtazapine is metabolized by CYP2D6 and CYP1A2[1].
|
-
-
- HY-W021008S
-
|
|
|
Sotolone-d2 (Dimethylhydroxyfuranone-d2) is deuterated labeled Sotolone. Sotolone is an activator of the human olfactory receptor OR8D1. Sotolone activates the human olfactory receptor OR8D1, with EC50 values of 84.98 μM and 167.2 μM for its S-enantiomer and R-enantiomer, respectively. Sotolone has unique aroma profiles: (R)-sotolone exhibits smoky, burnt, herbal and grassy notes; (S)-sotolone presents sweet, milky, sour and nutty notes. Sotolone also acts as an antifungal agent, showing moderate inhibitory activity against Magnaporthe oryzae in vitro .
|
-
-
- HY-121203S6
-
|
|
|
Citalopram-d4 (oxalate) is the deuterium labeled Citalopram oxalate (HY-121203A). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission .
|
-
| Cat. No. |
Product Name |
|
Classification |
-
- HY-14200
-
|
TVP1022; S-PAI
|
|
Alkynes
|
|
(S)-Rasagiline (TVP1022) is the relatively inactive S-enantiomer form of Rasagiline. Rasagiline is a highly potent selective irreversible MAO inhibitor with IC50s of 4.43 nM and 412 nM for rat brain MAO B and A activity, respectively . (S)-Rasagiline is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-16776A
-
|
(2S,5S)-Festinavir; (2S,5S)-BMS-986001; (2S,5S)-OBP-601
|
|
Alkynes
|
|
(2S,5S)-Censavudine ((2S,5S)-OBP-601) is the (2S,5S)-enantiomer of Censavudine. Censavudine, a nucleoside reverse transcriptase inhibitor, is a potent HIV inhibitor . (2S,5S)-Censavudine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: